We are extremely proud to announce that Karma Oncology has been selected as the only Scottish company to join the EU-Japan Biotech Mission. As such we will be in Osaka on 10 October for the Business Meeting with Japanese Life Sciences Industries then Yokohama for Bio Japan, 11 – 13 October. Please contact Tracey (email@example.com)
Below are two interesting articles that show the difference in monitoring styles. As a small CRO (David) our CRAs are experienced, flexible, reliable, mature and not representative of what you read in these articles (Goliath)! Contract Research Agonizations http://www.outsourcing-pharma.com/Commercial-Services/CRO-turnover-creates-loss-of-continuity?utm_source=newsletter_daily&utm_medium=email&utm_campaign=31-May-2017&c=a9sXZMbHWbjGbUD%2FnbKhPrkUaWbnQMei&p2
We are delighted to announce that Karma Oncology Ltd. has been approved by the French Ministry of Higher Education, Research and Innovation for the French R&D tax credit scheme.
What a great night we had at the Scottish Development International Reception in the Don Room at the El Cortez here in San Diego! A dram of Scottish Malt Whiskies, wines and beers were on the menu as well as good company and lots of chat. Looking forward to another successful day at the BIO
Exciting times this week at the BIO International Conference in San Diego! Follow us on Twitter @KarmaOncology to see what we are up to both at and away from booth 5023.
Our leadership team are excited to be attending BIO International Convention in San Diego next week. Will you be attending? Come along to booth 5023 for a chat. Karma_BIO 2017 San Diego_May17